Free · 13,591 studies indexed

lighttherapyresearch.com is a free index of research on photobiomodulation and light therapy, gathered from the world’s journals and trial registries.

Sections
Other

Photobiomodulation Alleviates Insulin Resistance Induced by Intermittent Hypoxia, Through Preservation of Adipose Tissue Insulin Signaling and Reduction of Hepatic Oxidative Stress in Mice

PBM alleviates systemic insulin resistance, restores eWAT insulin signaling, and limits hepatic oxidative stress induced by IH. By enhancing insulin sensitivity, PBM could be proposed as a new therapeutic strategy against OSA-associated metabolic comorbidities.

Excerpt from the paper’s abstract. Read the full paper for the details.

AI-generated summary

In this mouse study, the authors examined whether photobiomodulation, a low-level red light therapy, could prevent insulin resistance caused by intermittent hypoxia, a feature of sleep apnea. They report that the light treatment improved insulin sensitivity, preserved insulin signaling in fat tissue, and reduced hepatic oxidative stress in hypoxia-exposed mice. The findings come from an animal model and may not apply directly to humans.

Who or what was studied
Male C57BL/6J mice randomized into four groups (normoxia or intermittent hypoxia, with or without photobiomodulation)
Wavelengths
630 nm
Limits stated in the abstract
The study was conducted in mice over two weeks, so the results may not translate to humans with sleep apnea.

Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.

Abstract

Aim

Chronic intermittent hypoxia (IH), a hallmark of obstructive sleep apnea (OSA), contributes to metabolic diseases and enhances associated cardiovascular (CV) complications through oxidative stress and metabolic alterations. We hypothesize that photobiomodulation (PBM), a non-invasive low-level laser therapy, prevents IH-induced insulin resistance (IR), by preserving insulin signalization and reducing oxidative stress in insulin-sensitive organs.

Methods

Male C57BL/6J mice were randomized in 4 groups, submitted to either 2-weeks IH (21%-5% FiO2, 60 s cycle, 8 h/day) or normoxia (N), with or without PBM (630 nm, 5 J/cm2, 32 mW, 120 s, 5 days/week). At day 11, insulin sensitivity was assessed by insulin tolerance test. Then, canonical insulin signaling pathway was explored by western-blot, and oxidative stress was assessed by measurement of enzymatic activity, O2·- content, and lipid and protein oxidation in liver, gastrocnemius (GC) muscle, and epididymal white adipose tissue (eWAT).

Results

IH induces systemic IR, impairs insulin signaling in liver and eWAT, and increases hepatic O2·- content, while pro/anti-oxidant enzyme activities were unchanged. Interestingly, in IH group only, PBM significantly improves systemic insulin sensitivity, prevents eWAT insulin signaling alteration and decreases hepatic O2·- content.

Conclusion

PBM alleviates systemic insulin resistance, restores eWAT insulin signaling, and limits hepatic oxidative stress induced by IH. By enhancing insulin sensitivity, PBM could be proposed as a new therapeutic strategy against OSA-associated metabolic comorbidities.

Abstract reproduced under the CC BY license. Source: PubMed, a service of the National Library of Medicine.

Light parameters mentioned

Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.

Wavelength
630 nm
Energy density (fluence)
5 J/cm2
Power
32 mW
Total energy
6J

How to read a single study: what to check before relying on this kind of research.

Terms in this paper: Photobiomodulation, Oxidative stress, Low-level laser therapy, Laser. Each links to its definition in the glossary.

A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.

Related studies